We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

78 hedge funds and large institutions have $516M invested in GenMark Diagnostics, Inc in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 19

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

9% more capital invested

Capital invested by funds: $474M → $516M (+$42M)

7% more funds holding

Funds holding: 73 → 78 (+5)

18% less call options, than puts

Call options by funds: $9K | Put options by funds: $11K

Holders
78
Holders Change
+5
Holders Change %
+6.85%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
35
Reduced
19
Closed
8
Calls
$9K
Puts
$11K
Net Calls
-$2K
Net Calls Change
+$18K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$5.62M
2
PI
Putnam Investments
Massachusetts
+$4.42M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.94M
4
CCM
Cadian Capital Management
New York
+$3.89M
5
Ameriprise
Ameriprise
Minnesota
+$3.29M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$18.9M
2
PHS
PFM Health Sciences
California
-$7.89M
3
Citadel Advisors
Citadel Advisors
Florida
-$5.11M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.14M
5
Artisan Partners
Artisan Partners
Wisconsin
-$2.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
GA
51
Geneva Advisors
Illinois
$342K +$1.6K +132 +0.5%
AIG
52
American International Group
New York
$333K +$51.9K +4,272 +21%
Millennium Management
53
Millennium Management
New York
$332K +$304K +25,000 New
BA
54
BlackRock Advisors
Delaware
$323K +$22.4K +1,848 +8%
U
55
UBS
Switzerland
$313K -$32.1K -2,642 -10%
AQR Capital Management
56
AQR Capital Management
Connecticut
$311K – – –
VOYA Investment Management
57
VOYA Investment Management
Georgia
$304K – – –
CS
58
Credit Suisse
Switzerland
$271K +$49.4K +4,067 +25%
DC
59
Deere & Company
Illinois
$260K – – –
Two Sigma Investments
60
Two Sigma Investments
New York
$246K +$224K +18,462 New
Principal Financial Group
61
Principal Financial Group
Iowa
$242K +$220K +18,156 New
GC
62
Guggenheim Capital
Illinois
$203K +$14K +1,155 +8%
Jane Street
63
Jane Street
New York
$167K +$153K +12,579 New
HighTower Advisors
64
HighTower Advisors
Illinois
$158K – – –
FAM
65
Fred Alger Management
New York
$114K +$27.6K +2,275 +36%
Wells Fargo
66
Wells Fargo
California
$112K +$14.6K +1,200 +17%
MAA
67
Managed Account Advisors
New Jersey
$109K +$99.3K +8,177 New
TWA
68
TCI Wealth Advisors
Arizona
$80K – – –
NTCOC
69
Northern Trust Company of Connecticut
Connecticut
$73K – – –
TRCT
70
Tower Research Capital (TRC)
New York
$59K -$8.02K -660 -13%
TDC
71
Thompson Davis & Co
Virginia
$47K +$42.5K +3,500 New
Bank of Montreal
72
Bank of Montreal
Ontario, Canada
$27K – – –
Barclays
73
Barclays
United Kingdom
$25K +$6.32K +520 +37%
GT
74
Glenmede Trust
Pennsylvania
$13K – – –
BlackRock
75
BlackRock
New York
$12K +$1.53K +126 +17%
1 2
3
4

GNMK Hedge Fund Activity: Q4 2013 in Review

78 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2013, worth a combined $516M — up 8.9% from $474M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GNMK positions and 8 closed out — a net gain of 5 holders — while 35 added to existing stakes and 19 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $5.62M. The largest seller was T. Rowe Price Associates, cutting an estimated $18.9M.

  • 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2013, up from 73 in Q3 2013.
  • Funds reported $516M of GenMark Diagnostics, Inc stock for Q4 2013, up 8.9% quarter-over-quarter.
  • 13 funds opened new GenMark Diagnostics, Inc positions in Q4 2013 and 8 closed out, a net change of +5 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2013 was JP Morgan Chase, an estimated $5.62M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2013 was T. Rowe Price Associates, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2013.